These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23265900)

  • 21. Novel benzimidazo[2,1-c][1,4]thiazinone derivatives with potent activity against HSV-1.
    Galal SA; El-Naem SI; El-Nezhawy AO; Ali MA; El-Diwani HI
    Arch Pharm (Weinheim); 2011 Apr; 344(4):255-63. PubMed ID: 21469175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Respiratory syncytial virus fusion inhibitors. Part 5: Optimization of benzimidazole substitution patterns towards derivatives with improved activity.
    Wang XA; Cianci CW; Yu KL; Combrink KD; Thuring JW; Zhang Y; Civiello RL; Kadow KF; Roach J; Li Z; Langley DR; Krystal M; Meanwell NA
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4592-8. PubMed ID: 17576060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and antiviral activity against Coxsackie virus B3 of some novel benzimidazole derivatives.
    Cheng J; Xie J; Luo X
    Bioorg Med Chem Lett; 2005 Jan; 15(2):267-9. PubMed ID: 15603937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, antiviral and antitumor activity of 2-substituted-5-amidino-benzimidazoles.
    Starcević K; Kralj M; Ester K; Sabol I; Grce M; Pavelić K; Karminski-Zamola G
    Bioorg Med Chem; 2007 Jul; 15(13):4419-26. PubMed ID: 17482821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery and Synthesis of Heterocyclic Carboxamide Derivatives as Potent Anti-norovirus Agents.
    Ohba M; Oka T; Ando T; Arahata S; Ikegaya A; Takagi H; Ogo N; Owada K; Kawamori F; Wang Q; Saif LJ; Asai A
    Chem Pharm Bull (Tokyo); 2016; 64(5):465-75. PubMed ID: 27150478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Respiratory syncytial virus fusion inhibitors. Part 6: an examination of the effect of structural variation of the benzimidazol-2-one heterocycle moiety.
    Combrink KD; Gulgeze HB; Thuring JW; Yu KL; Civiello RL; Zhang Y; Pearce BC; Yin Z; Langley DR; Kadow KF; Cianci CW; Li Z; Clarke J; Genovesi EV; Medina I; Lamb L; Yang Z; Zadjura L; Krystal M; Meanwell NA
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4784-90. PubMed ID: 17616396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of new benzimidazole-coumarin conjugates as anti-hepatitis C virus agents.
    Hwu JR; Singha R; Hong SC; Chang YH; Das AR; Vliegen I; De Clercq E; Neyts J
    Antiviral Res; 2008 Feb; 77(2):157-62. PubMed ID: 17977606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of novel small non-peptidic HIV-1 PIs: the benzothiophene ring as an effective moiety.
    Chiummiento L; Funicello M; Lupattelli P; Tramutola F; Berti F; Marino-Merlo F
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2948-50. PubMed ID: 22414613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Respiratory syncytial virus fusion inhibitors. Part 7: structure-activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivo.
    Sin N; Venables BL; Combrink KD; Gulgeze HB; Yu KL; Civiello RL; Thuring J; Wang XA; Yang Z; Zadjura L; Marino A; Kadow KF; Cianci CW; Clarke J; Genovesi EV; Medina I; Lamb L; Krystal M; Meanwell NA
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4857-62. PubMed ID: 19596574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and structure-activity relationship of heterocyclic analogs of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones as inhibitors of receptor tyrosine kinases.
    Frazier K; Jazan E; McBride CM; Pecchi S; Renhowe PA; Shafer CM; Taylor C; Bussiere D; He MM; Jansen JM; Lapointe G; Ma S; Vora J; Wiesmann M
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2247-51. PubMed ID: 16446087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure activity relationship (SAR) study of benzimidazole scaffold for different biological activities: A mini-review.
    Yadav G; Ganguly S
    Eur J Med Chem; 2015 Jun; 97():419-43. PubMed ID: 25479684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small molecule antagonists of the gonadotropin-releasing hormone (GnRH) receptor: structure-activity relationships of small heterocyclic groups appended to the 2-phenyl-4-piperazinyl-benzimidazole template.
    Hauze DB; Chengalvala MV; Cottom JE; Feingold IB; Garrick L; Green DM; Huselton C; Kao W; Kees K; Lundquist JT; Mann CW; Mehlmann JF; Rogers JF; Shanno L; Wrobel J; Pelletier JC
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1986-90. PubMed ID: 19251413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fused heterocyclic amido compounds as anti-hepatitis C virus agents.
    Aoyama H; Sugita K; Nakamura M; Aoyama A; Salim MT; Okamoto M; Baba M; Hashimoto Y
    Bioorg Med Chem; 2011 Apr; 19(8):2675-87. PubMed ID: 21458278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and antiviral activity of certain 5'-modified analogs of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole.
    Gudmundsson KS; Drach JC; Wotring LL; Townsend LB
    J Med Chem; 1997 Feb; 40(5):785-93. PubMed ID: 9057865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel research strategies of benzimidazole derivatives: a review.
    Barot KP; Nikolova S; Ivanov I; Ghate MD
    Mini Rev Med Chem; 2013 Aug; 13(10):1421-47. PubMed ID: 23544603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and pharmacological evaluation of benzannulated derivatives as potent and selective sigma-1 protein ligands.
    Donnier-Maréchal M; Carato P; Le Broc D; Furman C; Melnyk P
    Eur J Med Chem; 2015 Mar; 92():575-82. PubMed ID: 25602932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of a series of 2'-deoxy analogues of the antiviral agent 5,6-dichloro-2-isopropylamino-1-(beta-L-ribofuranosyl)-1H-benzimidazole (1263W94).
    Chan JH; Chamberlain SD; Biron KK; Davis MG; Harvey RJ; Selleseth DW; Dornsife RE; Dark EH; Frick LW; Townsend LB; Drach JC; Koszalka GW
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):101-23. PubMed ID: 10772705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and synthesis of bioactive adamantane spiro heterocycles.
    Kolocouris N; Zoidis G; Foscolos GB; Fytas G; Prathalingham SR; Kelly JM; Naesens L; De Clercq E
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4358-62. PubMed ID: 17588747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of novel benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptors.
    Hasegawa M; Nishigaki N; Washio Y; Kano K; Harris PA; Sato H; Mori I; West RI; Shibahara M; Toyoda H; Wang L; Nolte RT; Veal JM; Cheung M
    J Med Chem; 2007 Sep; 50(18):4453-70. PubMed ID: 17676829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and antiviral activity of alpha-nucleosides: D- and L-isomers of lyxofuranosyl- and (5-deoxylyxofuranosyl)benzimidazoles.
    Migawa MT; Girardet JL; Walker JA; Koszalka GW; Chamberlain SD; Drach JC; Townsend LB
    J Med Chem; 1998 Apr; 41(8):1242-51. PubMed ID: 9575044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.